This award recognizes three early-career authors, highlighting their exceptional research published in the journal and the profound impact it has had on the field of molecular pharmaceutics.
We are pleased to announce the winners of the inaugural Molecular Pharmaceutics Early Career Best Paper Award. The winners were selected based on the quality and potential impact of their research recently published in Molecular Pharmaceutics. Our winners are early career scientists (<10 years post Ph.D.) from one of three major geographical regions (the Americas, Europe/Middle East/Africa (EMEA), and Asia Pacific).
We received a significant number of nominations. The selection committee was impressed by the exceptionally high quality of the candidates. We thank everyone who submitted nominations for the 2024 Molecular Pharmaceutics Early Career Best Paper Award.
We are excited to announce the 2024 Molecular Pharmaceutics Early Career Best Paper Award winners from each region:
- Dr. Atabak Ghanizadeh Tabriz (EMEA)
- Dr. Huyen Tran (Americas)
- Dr. Piyushkumar Gondaliya (Asia Pacific)
Congratulations to the 2024 award recipients! Thank you to everyone who submitted their nomination, and we hope you will submit again next year.
As part of the award, the winners received the opportunity to present their research as part of ACS Publications' Winners Week 2024 webinar series—now available to watch on demand! Hear from the winners as they discuss their work and answer questions submitted by live attendees, moderated by Editor-in-Chief Prof. Lynne Taylor.
Read on to learn more about each winner and read their winning papers.
Dr. Atabak Ghanizadeh Tabriz
Winning Article: "3D Printed Flavor-Rich Chewable Pediatric Tablets Fabricated Using Microextrusion for Point of Care Applications"
Dr. Huyen Tran
Winning Article: "In Vivo Mechanism of Action of Sodium Caprate for Improving the Intestinal Absorption of a GLP1/GIP Coagonist Peptide"
Dr. Piyushkumar Gondaliya
Winning Article: "Mesenchymal Stem Cell-Derived Exosomes Loaded with miR-155 Inhibitor Ameliorate Diabetic Wound Healing"